Tuesday, July 17, 2018      
Choose Language  

Oxaliplatin - Alvoxal

Drug Name : Oxaliplatin - Alvoxal
Drug Category : AntineoPlastics
Pharmacological Category: آلکیله کننده ها / Alkylating agent
Brand Name : Alvoxal
Drug Forms :
 Injection, solution 50, 100 mg [concentrate, preservative free]: 5 mg/mL (10 mL, 20 mL)


The maximum dose of oxaliplatin that has been administered in a single infusion is 825 mg

Overdose: thrombocytopenia, hypersensitivity reaction, myelosuppression, nausea, vomiting, diarrhea and neurotoxicity

There is no known antidote for Oxaliplatin overdose

Patients suspected of receiving an overdose should be monitored, and supportive treatment should be administered

FDA Approval

Adjuvant Therapy for Stage III Colorectal Cancer; On November 4, 2004

Initial Therapy for Advanced Colorectal CancerOn January 9, 2004,